Gene mutations play critically important role in acute myeloid leukemia; Promising development for new treatments
Sunday, April 15, 2012 - 16:30
in Health & Medicine
The key to treating one of the most common types of human leukemia may lie within mutations in a gene called FLT3, according to new research. The work validates certain activating mutations in the FLT3 gene as targets for acute myeloid leukemia therapy -- a critically important finding for developing drugs.